Quantcast

Latest pharmaceutical industry Stories

2014-07-21 16:26:17

SAN FRANCISCO and DUBLIN, July 21, 2014 /PRNewswire/ -- Medicines360, a non-profit women's health pharmaceutical company, and Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Medicines360's New Drug Application (NDA) for Levosert(TM) (levonorgestrel), a hormonal intrauterine contraceptive (IUC) for use by women to prevent pregnancy. In June 2013, Medicines360 and...

2014-07-21 12:25:35

SAN ANTONIO, July 21, 2014 /PRNewswire-USNewswire/ -- ADB International Group Inc.: OTCQB: ADBI (ADBI or the Company) today announced a partnership with Austen BioInnovation Institute in Akron (ABIA or the Institute), for the purpose of bringing ADBI's E-QURE BST(TM), a bioelectrical signal therapy device (the E-QURE BST Device), to the U.S. market. The Institute, which has significant expertise in wound healing, clinical trial development and regulatory operations, will conduct a...

2014-07-21 12:25:25

PORTLAND, Oregon, July 21, 2014 /PRNewswire/ -- A new report by Allied Market Research titled, "Global biosimilars/follow-on-biologics market (types, applications and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020", suggests that the global biosimilars market would reach $35 billion by 2020 from the estimated $1.3 billion in 2013. Deeper penetration with clearer...

2014-07-21 12:25:16

ALBANY, New York, July 21, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "E-Clinical Solution Software Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020," the global microfluidic device market was valued at USD 3,005 million in 2014 and is expected to grow at a CAGR of 13.8% from 2014 to 2020, to reach an estimated value of USD 6,515.3 million in 2020. Browse the full E-Clinical...

2014-07-20 23:01:11

KRS Global Biotechnology, Inc., an FDA registered and inspected 503B Human Outsourcing Facility that specializes in the preparation of drugs no longer commercially available or in short supply, announces today that they are providing the service of compounded nitroglycerin. Boca Raton, FL (PRWEB) July 20, 2014 KRS Global Biotechnology, Inc. is pleased to announce that it is providing the compounding service of nitroglycerin. Aside from authorized international shipments of the drug into...

2014-07-20 23:00:10

Membrane filtration is a widely used separation technique in the pharmaceutical and biotechnology industries and its adoption rate in Europe and North America is very high - http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html. (PRWEB) July 21, 2014 The “Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein...

2014-07-18 23:01:05

In May 2014, the FDA released a draft guidance that covers the selection and approval process for proposed names of both prescription and nonprescription human drugs and biologics. FDAnews has teamed with drug-naming expert Dr. Susan Proulx to present a 90-minute webinar that will look closely at the draft guidance and its recommended 4-step process. Falls Church, VA (PRWEB) July 18, 2014 Choosing the Right Drug Name: How to Increase Your Chances for Approval **FDAnews Webinar** July...

2014-07-18 20:21:37

CHAPEL HILL, N.C., July 18, 2014 /PRNewswire/ -- Patient engagement is a critical success factor in pharmaceutical marketing today. Although marketing is one of the principal groups that handle patient engagement activities, Government Affairs and Public Policy groups within the pharmaceutical industry are among the functions that are becoming increasingly involved in activities and initiatives to positively impact the "patient journey." Recent research by benchmarking firm, Best Practices,...

2014-07-18 16:23:22

TARRYTOWN, N.Y., July 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2014 financial and operating results on Tuesday, August 5, 2014, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International). A link to the...

2014-07-18 16:21:29

MINNEAPOLIS, MN, July 18, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA), an industrial biotechnology company producing renewable chemicals, announced today that it will report its financial results for the second quarter 2014 on Thursday August 7, 2014. BioAmber will also hold a live investor conference call and webcast at 4:30 PM Eastern Time (1:30 PM PT) to discuss the results. Conference Call and Webcast Thursday, August 7, 2014 @ 4:30 PM Eastern Time / 1:30 PM Pacific Time...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related